Cargando…

High-Density Single Nucleotide Polymorphism Genome-Wide Linkage Scan for Susceptibility Genes for Diabetic Nephropathy in Type 1 Diabetes: Discordant Sibpair Approach

OBJECTIVE— Epidemiological and family studies have demonstrated that susceptibility genes play an important role in the etiology of diabetic nephropathy, defined as persistent proteinuria or end-stage renal disease (ESRD) in type 1 diabetes. RESEARCH DESIGN AND METHODS— To efficiently search for gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rogus, John J., Poznik, G. David, Pezzolesi, Marcus G., Smiles, Adam M., Dunn, Jonathon, Walker, William, Wanic, Krzysztof, Moczulski, Dariusz, Canani, Luis, Araki, Shinichi, Makita, Yuichiro, Warram, James H., Krolewski, Andrzej S.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2008
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518505/ https://www.ncbi.nlm.nih.gov/pubmed/18559660 http://dx.doi.org/10.2337/db07-1086

Ejemplares similares

Exclusion of Polymorphisms in Carnosinase Genes (CNDP1 and CNDP2) as a Cause of Diabetic Nephropathy in Type 1 Diabetes: Results of Large Case-Control and Follow-Up Studies
por: Wanic, Krzysztof, et al.
Publicado: (2008)

Genome-Wide Association Scan for Diabetic Nephropathy Susceptibility Genes in Type 1 Diabetes
por: Pezzolesi, Marcus G., et al.
Publicado: (2009)

Confirmation of Genetic Associations at ELMO1 in the GoKinD Collection Supports Its Role as a Susceptibility Gene in Diabetic Nephropathy
por: Pezzolesi, Marcus G., et al.
Publicado: (2009)

Family-Based Association Analysis Confirms the Role of the Chromosome 9q21.32 Locus in the Susceptibility of Diabetic Nephropathy
por: Pezzolesi, Marcus G., et al.
Publicado: (2013)

The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end stage renal disease
por: Skupien, Jan, et al.
Publicado: (2012)

Circulating TGF-β1–Regulated miRNAs and the Risk of Rapid Progression to ESRD in Type 1 Diabetes
por: Pezzolesi, Marcus G., et al.
Publicado: (2015)

Transcriptome Analysis of Proximal Tubular Cells (HK-2) Exposed to Urines of Type 1 Diabetes Patients at Risk of Early Progressive Renal Function Decline
por: Wanic, Krzysztof, et al.
Publicado: (2013)

Familial, structural, and environmental correlates of MRI-defined bone marrow lesions: a sibpair study
por: Zhai, Guangju, et al.
Publicado: (2006)

Increased plasma Kidney Injury Molecule-1 suggests early progressive renal decline in non-proteinuric patients with Type 1 diabetes
por: Nowak, Natalia, et al.
Publicado: (2016)

Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes
por: Krolewski, Andrzej S., et al.
Publicado: (2012)

Early Progressive Renal Decline Precedes the Onset of Microalbuminuria and Its Progression to Macroalbuminuria
por: Krolewski, Andrzej S., et al.
Publicado: (2014)

Renal Hyperfiltration and the Development of Microalbuminuria in Type 1 Diabetes
por: Ficociello, Linda H., et al.
Publicado: (2009)

Serum Levels of Advanced Glycation Endproducts and Other Markers of Protein Damage in Early Diabetic Nephropathy in Type 1 Diabetes
por: Perkins, Bruce A., et al.
Publicado: (2012)

Uremic solutes and risk of end stage renal disease in type 2 diabetes
por: Niewczas, Monika A, et al.
Publicado: (2014)

Progressive Renal Decline: The New Paradigm of Diabetic Nephropathy in Type 1 Diabetes
por: Krolewski, Andrzej S.
Publicado: (2015)

From Single Nucleotide Polymorphism to Transcriptional Mechanism: A Model for FRMD3 in Diabetic Nephropathy
por: Martini, Sebastian, et al.
Publicado: (2013)

Animal Models of Diabetes and Metabolic Disease 2014
por: Sasase, Tomohiko, et al.
Publicado: (2015)

Synergism Between Circulating Tumor Necrosis Factor Receptor 2 and HbA(1c) in Determining Renal Decline During 5–18 Years of Follow-up in Patients With Type 1 Diabetes and Proteinuria
por: Skupien, Jan, et al.
Publicado: (2014)

Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type-1 diabetes
por: Merchant, Michael L., et al.
Publicado: (2013)

Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease
por: Niewczas, Monika A., et al.
Publicado: (2017)

Animal Models of Diabetes and Metabolic Disease
por: Sasase, Tomohiko, et al.
Publicado: (2013)

Rotten to the Cortex: Ceramide-Mediated Lipotoxicity in Diabetic Kidney Disease
por: Nicholson, Rebekah J., et al.
Publicado: (2021)

Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy
por: Skupien, Jan, et al.
Publicado: (2019)

Linkage analysis of alcohol dependence using both affected and discordant sib pairs
por: Shih, Pei-Ying, et al.
Publicado: (2005)

The HD-OCT Study May Be Useful in Searching for Markers of Preclinical Stage of Diabetic Retinopathy in Patients with Type 1 Diabetes
por: Kołodziej, Magdalena, et al.
Publicado: (2019)

Discordance in risk factors for the progression of diabetic retinopathy and diabetic nephropathy in patients with type 2 diabetes mellitus
por: Song, Ki‐Ho, et al.
Publicado: (2018)

Risk of ESRD and All Cause Mortality in Type 2 Diabetes According to Circulating Levels of FGF-23 and TNFR1
por: Lee, Jung Eun, et al.
Publicado: (2013)

Nerve decompression and neuropathy complications in diabetes: Are attitudes discordant with evidence?
por: Nickerson, D. Scott
Publicado: (2017)

Establishing chronic condition concordance and discordance with diabetes: a Delphi study
por: Magnan, Elizabeth M, et al.
Publicado: (2015)

Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383–390
por: Niewczas, Monika A., et al.
Publicado: (2017)

Erratum. Clinical Course of Myocardial Infarction Among Diabetic Patients. Diabetes Care 1980;3:526–529
por: Czyżk, Artur, et al.
Publicado: (2017)

High-Normal Serum Uric Acid Increases Risk of Early Progressive Renal Function Loss in Type 1 Diabetes: Results of a 6-year follow-up
por: Ficociello, Linda H., et al.
Publicado: (2010)

The associations between COVID-19 diagnosis, type 1 diabetes, and the risk of diabetic ketoacidosis: A nationwide cohort from the US using the Cerner Real-World Data
por: Qeadan, Fares, et al.
Publicado: (2022)

The role of progranulin in diabetes and kidney disease
por: Nicoletto, Bruna Bellincanta, et al.
Publicado: (2015)

Patient with lupus anticoagulant caused aPTT prolongation corrected with prednisolone treatment and later anticoagulation treatment due to chronic atrial fibrillation
por: Frydrysiak, Marlena, et al.
Publicado: (2023)

Hyperglycemia Regulated Circulating MicroRNAs and Their Effects on Renal Function Decline in Type 2 Diabetes
por: Kobayashi, Hiroki, et al.
Publicado: (2021)

Discordant vascular parameter measurements in diabetic and non-diabetic eyes detected by different optical coherence tomography angiography devices
por: Chen, Yi, et al.
Publicado: (2020)

A dominant negative ADIPOQ mutation in a diabetic family with renal disease, hypoadiponectinemia, and hyperceramidemia
por: Simeone, Christopher A., et al.
Publicado: (2022)

Gene Expression Differences in Skin Fibroblasts in Identical Twins Discordant for Type 1 Diabetes
por: Caramori, M. Luiza, et al.
Publicado: (2012)

Cardio-Metabolic Features of Type 2 Diabetes Subjects Discordant in the Diagnosis of Metabolic Syndrome
por: Lee, Sa Rah, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vmmtek9vd66iare9u63keetrk0